Professor Junichi Ishii
Fujita Health University Second Hospital, Nagoya (Japan)
Circulating presepsin (soluble CD14 subtype) as a novel marker of mortality in patients treated at medical cardiac intensive care units
Event: ESC Congress 2020
Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care
Session: Cardiac ITU Is about the Heart, and More
Circulating concentration of presepsin improves early prediction of short-term mortality in patients treated at medical cardiac intensive care units
Event: ESC Congress 2019
Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care
Session: Acute coronary syndrome no-reflow
Combination of presepsin, soluble CD14 subtype, and B-type natriuretic peptide predicts six-month mortality in patients hospitalized for worsening heart failure
Event: ESC Congress 2018
Topic: Biomarkers
Session: "Biomarkers reloaded": Diagnosis and prognosis of acute heart failure
Circulating presepsin (soluble CD14 subtype) as a novel marker of mortality in patients treated at medical cardiac intensive care units
Event: ESC Asia with APSC & AFC 2020
Topic: Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care
Session: Abstract Programme
ESC 365 is supported by
